Total Payments
$730.47
2024 Payments
$91.81
Companies
11
Transactions
32
Medicare Patients
5,034
Medicare Billing
$221,179
Payment Breakdown by Category
Food & Beverage$730.47 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $730.47 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $209.65 | 5 | $0 (2024) |
| Novo Nordisk Inc | $208.88 | 8 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $97.94 | 6 | $0 (2023) |
| PFIZER INC. | $56.66 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $35.93 | 2 | $0 (2023) |
| GlaxoSmithKline, LLC. | $23.95 | 2 | $0 (2022) |
| Nestle HealthCare Nutrition Inc. | $23.83 | 2 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $22.24 | 1 | $0 (2021) |
| Lilly USA, LLC | $20.63 | 1 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $17.95 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $91.81 | 4 | ABBVIE INC. ($67.91) |
| 2023 | $255.08 | 11 | Novo Nordisk Inc ($155.87) |
| 2022 | $284.33 | 11 | ABBVIE INC. ($141.74) |
| 2021 | $99.25 | 6 | E.R. Squibb & Sons, L.L.C. ($28.84) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.80 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/26/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Diabetes | ||||||
| 09/28/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: PAIN | ||||||
| 06/08/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Obesity | ||||||
| 05/03/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: PAIN | ||||||
| 05/01/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $1.38 | General |
| Category: Obesity | ||||||
| 04/26/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.70 | General |
| Category: Obesity | ||||||
| 04/12/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: ETONOGESTREL | ||||||
| 03/24/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.44 | General |
| Category: Cardiovascular | ||||||
| 02/23/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Obesity | ||||||
| 01/11/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: Diabetes | ||||||
| 11/10/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: PRIMARY CARE | ||||||
| 09/27/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Obesity | ||||||
| 09/27/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Obesity | ||||||
| 07/29/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.27 | General |
| Category: Cardiovascular | ||||||
| 07/15/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/17/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.43 | General |
| Category: Cardiovascular | ||||||
| 04/01/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.96 | General |
| Category: Cardiovascular | ||||||
| 03/17/2022 | Nestle HealthCare Nutrition Inc. | — | Food and Beverage | In-kind items and services | $12.03 | General |
| 03/10/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $123.96 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,542 | 1,907 | $326,640 | $69,969 |
| 2022 | 18 | 1,158 | 1,487 | $266,306 | $59,434 |
| 2021 | 21 | 1,288 | 1,603 | $223,650 | $55,692 |
| 2020 | 15 | 1,046 | 1,264 | $168,567 | $36,084 |
Total Patients
5,034
Total Services
6,261
Medicare Billing
$221,179
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 303 | 447 | $185,505 | $39,550 | 21.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 153 | 180 | $53,100 | $11,439 | 21.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 203 | 284 | $5,690 | $2,342 | 41.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 14 | $8,190 | $1,991 | 24.3% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 20 | 22 | $4,425 | $1,986 | 44.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 149 | 170 | $11,390 | $1,749 | 15.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 33 | 34 | $2,380 | $1,670 | 70.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 91 | 94 | $7,896 | $1,207 | 15.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 92 | 121 | $7,381 | $1,140 | 15.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 122 | 136 | $6,664 | $1,022 | 15.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 14 | 14 | $1,540 | $1,007 | 65.4% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 26 | 26 | $10,530 | $971.88 | 9.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 47 | 52 | $5,512 | $855.92 | 15.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $560.00 | $531.20 | 94.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 108 | 131 | $2,620 | $404.30 | 15.4% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 21 | 21 | $2,436 | $397.32 | 16.3% |
| 87480 | Detection test for candida species (yeast), direct probe technique | Office | 2023 | 16 | 20 | $2,520 | $393.00 | 15.6% |
| 87510 | Detection test for gardnerella vaginalis (bacteria), direct probe technique | Office | 2023 | 16 | 20 | $2,520 | $393.00 | 15.6% |
| 87660 | Detection test by nucleic acid for trichomonas vaginalis (genital parasite), direct probe technique | Office | 2023 | 16 | 20 | $2,520 | $393.00 | 15.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 24 | 24 | $1,200 | $252.00 | 21.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 12 | 12 | $684.00 | $106.08 | 15.5% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 12 | 12 | $624.00 | $69.52 | 11.1% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 11 | 13 | $429.00 | $66.04 | 15.4% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 12 | 12 | $204.00 | $31.80 | 15.6% |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | Office | 2023 | 12 | 12 | $120.00 | $1.14 | 1.0% |
About Peggy Jesse, ARNP
Peggy Jesse, ARNP is a Family healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1790811057.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Peggy Jesse, ARNP has received a total of $730.47 in payments from pharmaceutical and medical device companies, with $91.81 received in 2024. These payments were reported across 32 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($730.47).
As a Medicare-enrolled provider, Jesse has provided services to 5,034 Medicare beneficiaries, totaling 6,261 services with total Medicare billing of $221,179. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Seattle, WA
- Active Since 02/23/2007
- Last Updated 07/08/2007
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1790811057
Products in Payments
- UBRELVY (Drug) $193.95
- Wegovy (Drug) $147.08
- ELIQUIS (Drug) $97.94
- NURTEC ODT (Drug) $72.95
- Saxenda (Drug) $33.01
- PAXLOVID (Drug) $23.90
- JARDIANCE (Drug) $20.63
- RYBELSUS (Drug) $20.00
- FARXIGA (Drug) $19.57
- BREZTRI (Drug) $16.36
- VRAYLAR (Drug) $15.70
- NEXPLANON (Drug) $12.81
- SHINGRIX (Biological) $12.14
- TRELEGY ELLIPTA (Drug) $11.81
- ZENPEP (Drug) $11.80
- Ozempic (Drug) $8.79
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Seattle
Dr. Kevan Petterson, Dnp, Fnp, DNP, FNP
Family — Payments: $55,987
Family $55,987
Dr. Kaitlin Brasier, D.n.p., A.r.n.p., Rn, D.N.P., A.R.N.P., RN
Family — Payments: $27,842
Family $27,842
Ms. Karen Johnson, Arnp, ARNP
Family — Payments: $14,117
Family $14,117
Omeid Heidari, Phd, Msn, Anp-C, PHD, MSN, ANP-C
Family — Payments: $12,629
Family $12,629
Lilly Silva, Rn, Fnp, Msn, RN, FNP, MSN
Family — Payments: $9,101
Family $9,101
Amy Perez, Fnp, FNP
Family — Payments: $8,589
Family $8,589